From the June 2017 issue of HealthCare Business News magazine




Digirad
Cardius X-ACT+
Digirad’s Cardius X-ACT+ diagnostic imaging system raises the bar in nuclear cardiology with its advanced SPECT/FAC technology, nSPEED 3D-OSEM and TruACQ count-based Imaging for customized SPECT MPI. Its triple-head, solid-state detectors and fully integrated ultra-low dose Fluorescence Attenuation Correction allow for high specificity imaging, reduced patient dose, excellent image quality and superb reliability. Its patient-friendly, open gantry design helps to comfortably image bariatric patients up to 500 pounds, as well as claustrophobic and COPD patients.




GE Healthcare
Discovery NM/CT 670 CZT
Bring theory to life with CZT!
The world’s first commercially available general purpose SPECT/CT system powered by CZT technology. Help bring your theories to life with a system designed to leverage all that CZT can do. Engineered for improvements in lesion detection, image quality and patient comfort, and combined with advanced quantitative applications provided through Xeleris, this system renews the promise of nuclear medicine's potential for true discovery.



GE Healthcare
Discovery NM530c
• The Discovery NM530c, with CZT-based Alcyone technology, redefines what's possible in nuclear cardiology.
• An innovative, dedicated cardiac gamma camera, with up to 4 times lower injected dose compared to conventional detector technology.
• Alcyone’s heightened sensitivity and zero equipment motion improve both image quality and energy resolution, enabling the potential for new clinical applications including 3-D dynamic acquisitions and simultaneous dual isotope imaging.



GE Healthcare
Discovery 670 DR
Designed to help you lead clinical discovery with hybrid imaging. It’s a premium SPECT/CT system with the added flexibility of a standalone diagnostic CT. It delivers the accurate, reproducible results referring physicians require in a comfortable and streamlined exam experience. Digital-detection-ready platform secures your investment with an easy upgrade path to Discovery NM/CT 670 CZT to deliver CZT technology. Pursue improved clinical, operational and economic outcomes with a system ready to leverage advancements in digital solutions.

June 2017 Magazine

Read more stories from the June 2017 issue

More Product Showcase

Molecular Imaging Homepage